Researchers at Colorado State University found that plague in prairie dogs can provide key insights into the study of rare infectious diseases like Ebola. The disease's spread is influenced by ecological factors, including temperature and population dynamics.
Researchers have engineered antibodies that can potently neutralize Zaire and Sudan Ebola virus strains, providing high levels of protection for mice exposed to lethal doses. The findings are a significant step toward developing an all-inclusive treatment for Ebola virus that causes human disease.
A quick screening method has been used to identify and test promising anti-Ebola drugs. The method, which allows for the evaluation of candidate drugs and comparison of antiviral effectiveness, has shown potential in reducing the emergence of drug resistance and increasing confidence in experimental results.
A team of healthcare workers developed guidelines for treating Ebola-infected children, recommending an aggressive approach that includes fluid therapy, highly fortified food, and increased bedside care. The protocol aims to improve survival rates among young patients and provide a basis for future outbreaks.
A review analysis suggests that patient location and travel mapping limitations contributed to the Ebola epidemic's spread. Employing community members in mapping and education could have helped contain the outbreak.
The Walter Reed Army Institute of Research is conducting a Phase 2 clinical trial to evaluate the safety and immunogenicity of an Ebola vaccine regimen in healthy and HIV-infected study volunteers. The trial includes two vaccine candidates and will assess their safety and immune response in volunteers up to 70 years old.
A recent study by Dr. Anthony Griffiths reveals that the Ebola virus has a high frequency of spontaneous mutation, which could prove useful for developing therapies. Increasing the mutation rate may make the virus non-viable, providing a potential therapeutic tool against the disease.
Experts recommend that researchers share their data and findings freely during public health crises, citing benefits of faster solutions to healthcare crises and advances in scientific collaboration. This shift towards data stewardship could simplify information sharing mechanisms and lead to greater transparency.
A new study has identified the factors contributing to the transmission of zoonotic diseases from bats to humans, highlighting areas at high risk in West Africa, sub-Saharan Africa, and South East Asia. The research used data spanning over 110 years to create a global map showing hotspots for bat-human virus transmission risk.
Researchers found that areas with high poverty levels were more likely associated with high Ebola transmission and spread. In contrast, lower socioeconomic status communities had a higher number of personal contacts, increasing the likelihood of transmission.
Researchers discovered a molecular 'arms race' between Ebola virus and African straw-colored fruit bats that may have started over 25 million years ago. The study sheds light on the biological factors determining which bat species harbor the virus, with potential applications for preventing future outbreaks.
The increased international trade and travel have led to the spread of infectious diseases, including zoonoses like SARS and MERS. The economic cost of these outbreaks can be significant, with the 2001 UK hoof and mouth disease outbreak costing over $10 billion.
A large study of Ebola survivors found that many reported complications such as vision and hearing problems, as well as joint pain, months after recovery. The study suggests that the virus may persist in certain bodily fluids and highlights the need for follow-up care in West Africa.
Researchers have discovered a compound that induces genes to control infection in several known viruses, including West Nile and Ebola. The findings show promising evidence for creating a broad-spectrum antiviral that can suppress a range of RNA viruses.
Researchers have solved the crystal structures of three human TIM members and found that they efficiently enhance Ebola virus infection. The study provides valuable information on the atomic interactions between phosphoserine and hTIMs.
A new rapid test using polarized light can detect a wide range of pathogens, including malaria parasites, HIV, Ebola, diverse bacteria, glucose and cholesterol. The test is extremely fast, inexpensive, and flexible, making it suitable for use in areas with limited laboratory equipment.
A comprehensive genomic analysis of Ebola virus sequences from Liberia reveals a single introduction source, followed by local spread and diversification. The study also identified reintroductions as a key factor in the continuation of the outbreak in Guinea.
Researchers used genome sequencing to trace Ebola's spread in Liberia, finding that most cases were linked to a single introduction of the virus in September 2014. The study suggests that widespread migration within Liberia contributed to the outbreak's magnitude and longevity.
The US has sufficient capacity to treat another Ebola outbreak, but challenges remain in providing necessary resources, staffing, and training. The study highlights issues with waste disposal, staffing, and pediatric care, emphasizing the need for further investigation and investment.
A new report reveals that increased funding for Ebola research and development comes at the expense of other neglected diseases, which cause more deaths annually than Ebola. Despite this, industry investment in R&D for Ebola, malaria, and HIV/AIDS increases, while funding for TB R&D decreases.
Researchers argue that investing in simple diagnostic tests like pulse oximetry can prevent pneumonia deaths and end disease epidemics in the under-fives. The tests could also detect infected individuals with malaria and Ebola, potentially eliminating these diseases.
A no-fault vaccine injury compensation fund is proposed to address liability concerns and ensure recipients are fairly compensated in rare cases of harm. The World Bank could oversee the program, which would provide rapid deployment of vaccines without hesitation due to liability concerns.
Researchers found that Ebola virus blood levels are strong predictors of fatality, with case fatality ratios increasing with viremia levels. The study used laboratory and clinical data from 699 patients to model the association between viremia and CFR.
Scientists from TSRI have shown how a previously unknown process promotes infection in dangerous viruses, such as dengue, West Nile, and Ebola. They also point to an experimental antibiotic called duramycin that inhibits infection by these deadly viruses, all of which lack vaccines and treatments.
A panel of global experts recommends 10 major reforms to strengthen the global system for outbreak prevention and response. The report highlights the need for improved governance, research data sharing, and rapid institutional responses to prevent future pandemics.
The International Health Regulations (IHR) face a 'crisis of confidence' following the Ebola epidemic. Georgetown experts recommend reforms to build core capacities, clarify reporting requirements, and strengthen emergency responses.
Researchers found that transmission in the general community is low-risk, with even living with someone infected not posing a significant threat if direct contact is avoided. The study recommends urgent diagnosis, hospitalization, and targeted vaccination strategies for close contacts and healthcare workers to stop the spread of Ebola.
A new Ebola vaccine has been found to be well-tolerated and stimulate strong immune responses in adults in Mali and the US. The study's findings could offer crucial protection for contacts of patients with confirmed Ebola disease, helping to interrupt transmission.
A new study found that gamma interferon, an FDA-approved drug, completely protects mice from death when given either before or up to 24 hours after exposure to Ebola. The treatment targets macrophages and blocks the infection of those initial cell targets, preventing a second round of infection.
A novel statistical model mapped the spread of the 2014-2015 Ebola outbreak in Sierra Leone, providing the most detailed picture to date. The analysis suggests two critical opportunities to control the epidemic and identifies two critical points where intervention could have been more effective.
Researchers designed a giant molecule formed by thirteen fullerenes covered by carbohydrates to block the Ebola virus receptor, inhibiting cell infection. The study highlights the potential of these giant molecules as antiviral agents, paving the way for new treatments.
A rapid-detection Ebola test developed by Dr. Manfred Weidmann has been deployed in Senegal and Guinea, performing exceptionally well under field conditions. The test uses a method called recombinase polymerase amplification and can be stored at room temperature, operated by local teams without the need for confirmatory tests.
Researchers have found a link between the origins of hepatitis A virus (HAV) and small mammals, specifically bats and rodents. The study provides novel insight into the evolution of HAV and how it spread to humans, highlighting the importance of analyzing animal reservoirs for risk assessment of emerging viruses.
A large-scale study reveals the hepatitis A virus is likely of animal origin, with viruses from small mammals showing similarities to the human virus. The discovery offers new perspectives for risk assessments and may hint at a distant ancestry in primordial insect viruses.
Research suggests that personal anxiety and mass media coverage interact to determine what people remember about a disease. The study found that selective media coverage can cause people to forget certain health facts, particularly those related to symptoms.
The study found that African immigrants experienced discrimination and stigma linked to the Ebola virus, leading to stress and hardships. The researchers emphasize the need for research on infectious diseases affecting immigrant communities in the US.
Experts identify self-disseminating vaccines as a potential solution to control emerging infectious diseases (EIDs) at their animal source. The vaccines use virus-based vectors to deliver vaccinations across populations, making it easier to inoculate animals and prevent disease transmission.
Researchers at Penn University discovered that inhibiting a calcium-signaling pathway can block the Ebola virus from exiting host cells and spreading, paving the way for potential broad-spectrum therapy. This approach has implications for treating multiple serious viral infections, including Marburg, Lassa, and Junin viruses.
The use of big data and analytics is crucial for managing chronic diseases in Singapore, where 48% of the disease burden is related to chronic illnesses. Data analytics can help identify patterns and correlations that improve healthcare outcomes and reduce costs.
A suspected case of sexual Ebola transmission was confirmed using genomic analysis, providing evidence of direct transmission between an EVD survivor and his partner. The study also shows the persistence of infectious EBOV in semen for over 179 days after disease onset.
Favipiravir successfully treats Lassa virus infection in guinea pigs, with high-dose treatment offering complete protection. The antiviral drug outperforms ribavirin, which can cause severe disease after treatment ends.
Researchers estimate that introducing Ebola treatment beds prevented an estimated 57,000 Ebola cases and 40,000 deaths in Sierra Leone. The study suggests that this could have been reduced further if the beds were introduced one month earlier.
A new antiviral compound, GS-5734, has shown 100% survival rate and significant reduction in viral load in infected rhesus monkeys. The compound's ability to block the virus's replication process suggests its potential as a treatment for Ebola virus disease.
James Munro of Tufts University School of Medicine has received the NIH Director's New Innovator Award to develop a new way to use single molecule imaging of Ebola glycoproteins. This research aims to inform the design of structure-based vaccines to fight the spread of Ebola.
The University of Massachusetts Medical School (UMMS) has been awarded a $20 million CDC grant to expand its efforts in preventing another Ebola outbreak in Liberia. The two-year grant will support training of healthcare workers, improvement of public health laboratory systems and hospital diagnostic services.
The University of Illinois at Chicago has been chosen as one of six research centers in the US to combat emerging infectious diseases. Researchers will study how healthcare workers can care for patients without putting themselves at risk, addressing concerns about Ebola and other diseases.
A UK university team has received funding to develop a training program for Sierra Leonean health workers to combat viral hemorrhagic fever. The program will use immersive technology to educate community health workers and healthcare professionals on infection prevention control.
Recent developments in surveillance technology could enable a swifter response to potentially deadly outbreaks of disease. A team of infectious disease experts found that shortcomings in the global response to Ebola highlight the need for state-of-the-art techniques to detect and monitor outbreaks.
A new test called ViroCap can detect viruses at low levels and identify variant strains, making it especially useful in situations where diagnosis remains elusive. The test increases sensitivity by 52% compared to standard testing, providing detailed genetic information about viral subtypes.
Researchers developed a real-time DNA sequencing test that can detect multiple pathogens, including Ebola, Chikungunya, and hepatitis C, using nanopore sequencing technology. The test can be used in scarce lab environments and provides rapid results, cutting the time required for diagnosis to just minutes.
A team at University of California - Santa Cruz developed chip-based technology for reliable Ebola detection, combining microfluidic and optofluidic chips. The system achieved comparable sensitivity to PCR analysis with excellent specificity.
University of Missouri researchers have discovered that Interferon Induced Transmembranes (IFITM) proteins can inhibit the transmission of HIV-1, the most common HIV strain. The study found that IFITM proteins specifically interact with the HIV-1 envelope glycoprotein and block its maturation, reducing viral infectivity and transmission.
The 'Tree of Life' for 2.3 million species has been released, depicting relationships among living things over time. The collaborative effort combines smaller trees from various sources, with the goal of creating a comprehensive and editable online resource.
A first draft of the 'tree of life' for 2.3 million named species has been released, combining existing branches into a single diagram. The digital resource was created by compiling thousands of smaller chunks and requires software tools to analyze and update.
Genetic mutations in Ebola virus appear to block antibody-based treatments from warding off infection. The mutations, or 'escape variants,' have implications for the continued development of therapeutics to treat Ebola virus disease, which has claimed over 11,000 lives in West Africa.
A $381,000 grant from the National Library of Medicine will support the development of open-source software tools to measure and monitor the quality of electronic data received by public health departments. The goal is to improve data quality, which will ultimately lead to better health outcomes.
Researchers mapped social vulnerability at the district level, identifying three clusters of most vulnerable districts containing over 1 million people. The study highlights the importance of addressing water quality, food insecurity, and access to medical care to prevent Ebola infections and deaths.
A new Ebola test using magnetic nanoparticles is 100 times more sensitive than current tests and easier to use, enabling faster isolation of patients and prevention of disease spread. This technology has potential applications in diagnosing other infectious diseases like flu and detecting tumors.
Leptospirosis is a poorly understood and often misdiagnosed bacterial disease with a high case fatality rate. The researchers aim to develop an inexpensive, sensitive, and efficient diagnostic test for leptospirosis, which could lead to improved clinical outcomes and reduced mortality.
A survey of primary care physicians found significant variation in how doctors make decisions in situations of uncertainty, with those least likely to encounter Ebola patients being most likely to choose overly intense management. The results highlight the need for additional resources and responsible reporting by news media.